FDA Grants Marketing Authorization to Edison Histotripsy System for Treatment of Liver Tumors

In part, FDA authorization was based on data from the #HOPE4LIVER trials conducted in 13 trial sites across the United States and Europe. Data pooled from the trials was used to assess the clinical safety and efficacy of histotripsy in destroying targeted primary and secondary liver tumors.

Access the full article to read more here.